Dermorphin and deltorphin heptapeptide analogues: Replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity

16Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The usefulness of 2,6-dimethylphenylalanine (Dmp) as a Phe surrogate in two opioid peptides, dermorphin (DM) and deltorphin II (DT), was investigated. Compared to DM, [L-Dmp3]DM (1) showed a 170-fold increase in μ affinity and only a 4-fold increase in δ affinity, resulting in a 40-fold improvement in μ receptor selectivity. Compared to DT, [L-Dmp3]DT (3) showed a 22-fold increase in δ affinity and somewhat of a loss in μ affinity, and consequently a marked (75-fold) improvement in δ receptor selectivity. The D-Dmp replacement, however, resulted in a great loss in receptor selectivity in each of the peptides. The specific receptor interactions of 1 and 3 were confirmed by in vitro bioassays. Analogues 1 and 3 seem to be useful as pharmacological tools for the study of opioid systems. © 2002 Elsevier Science Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Ambo, A., Murase, H., Niizuma, H., Ouchi, H., Yamamoto, Y., & Sasaki, Y. (2002). Dermorphin and deltorphin heptapeptide analogues: Replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity. Bioorganic and Medicinal Chemistry Letters, 12(6), 879–881. https://doi.org/10.1016/S0960-894X(02)00035-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free